NEXGEL, Inc. (NXGL) Stock Price & Analysis
NEXGEL, Inc. (NXGL) closed at USD 5.18 on Thursday, October 15, 2026, down 5.13% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 5.46; the Oct 15, 2026 session ranged USD 4.06–5.53 on volume of 164,251 shares. Market capitalization is $2.52M, with a 52-week range of USD 3–57 (NCM). Source: Nexqual, retrieved October 16, 2026 at 05:10 UTC.
Also available as compact Markdown for AI agents: nexqual.com/NXGL.md
Key facts (NXGL)
- Analysts: Hold (mean 3.00 on a 1–5 scale) (1 analysts).
- Total return with dividends: 1Y -89.0% vs S&P 500 +18.1%; 5Y -91.7% vs S&P 500 +85.1%.
- Next earnings: 2026-11-10, EPS estimate USD -4.8, revenue estimate $4.2M.
Analysts (NXGL)
Consensus Hold (mean 3.00 on a 1–5 scale), 1 analysts.
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-24 | Maxim Group | Downgrade | Buy → Hold |
Total return (dividends reinvested) (NXGL)
| 1Y (from 2025-10-16) | 5Y (from 2021-12-20) | |
|---|---|---|
| Total return | -89.0% | -91.7% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -89.1% | -40.3% |
| Volatility (annualized) | 125.4% | 76.0% |
| Max drawdown | -94.6% (Oct 2025→Oct 2026) | -96.3% (Dec 2024→Sep 2026) |
Key Statistics (as of October 16, 2026 at 05:10 UTC)
| Price | USD 5.18 |
|---|---|
| Change | ▼ 5.13% (down) |
| Previous Close | USD 5.46 |
| Open | USD 4.91 |
| Day Range | USD 4.06 – 5.53 |
| 52-Week Range | USD 3 – 57 |
| Volume | 164,251 shares |
| Market Cap | $2.52M |
| Exchange | NCM |
Technical Analysis (NXGL)
Nexqual's technical model rates NXGL "NEUTRAL" based on 2 bullish and 3 bearish signals across 127 daily candles, as of October 16, 2026 at 05:10 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 54.29 (neutral) |
| vs SMA50 | Below (USD 5.92) |
| MACD | -0.41 (negative) |
Analyst Ratings (NXGL)
Wall Street analysts rate NXGL "Hold" based on 1 analysts, per Nexqual as of October 16, 2026 at 05:10 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 1 |
| Buy / Hold / Sell | 0 / 1 / 0 |
Earnings (NXGL)
| Next Earnings Date | 2026-11-10 |
|---|---|
| EPS Estimate | USD -4.8 |
| Revenue Estimate | $4.19M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD -10.32 vs est -2.4 ▼ miss |
| 2026-03-31 | USD -2.2 vs est -1.4 ▼ miss |
| 2025-12-31 | USD -2.98 vs est -1.8 ▼ miss |
Source: Nexqual, October 16, 2026 at 05:10 UTC.
Financials & Fundamentals (NXGL)
| Total Revenue | $12.07M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +27.80% |
| Gross Margin | +35.08% |
| Operating Margin | -67.96% |
| Profit Margin | -51.26% |
| ROE | -115.06% |
| Debt / Equity | 1.36 |
| Current Ratio | 0.43 |
| Total Cash | $492,000 |
| Total Debt | $7.46M |
Source: Nexqual, October 16, 2026 at 05:10 UTC.
Financial Health Score (NXGL)
Nexqual rates NEXGEL, Inc.'s overall financial health "Weak" across five dimensions, as of October 16, 2026 at 05:10 UTC.
| Growth | Strong — Revenue +31% YoY (annual) |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Weak — $492K cash vs $7M debt |
| Cash Flow | Weak — Operating cash flow -$3M (TTM) |
| Efficiency | Critical — ROE -115%, ROA -18.7% |
Ownership (NXGL)
| Insider Ownership | +14.02% |
|---|---|
| Institutional Ownership | +13.67% |
| Shares Outstanding | 487,383 |
| Float | 383,887 |
| Short % of Float | +3.85% |
Source: Nexqual, October 16, 2026 at 05:10 UTC.
Leadership (NXGL)
NEXGEL, Inc. is led by Brian J. Kieser (age 58), Interim CEO & Director, per Nexqual as of October 16, 2026 at 05:10 UTC.
| Interim CEO & Director | Brian J. Kieser (age 58) |
|---|---|
| Chief Financial Officer | Ian Blackman (age 57) |
| Vice President of Operations | Gregory J. Robb |
| Managing Director of KCSA Strategic Communications | Valter Pinto |
Major Backers & Investors (NXGL)
Notable institutional backers of NEXGEL, Inc. include Susquehanna International Group, LLP, Virtu Financial LLC, HRT Financial LP, according to Nexqual as of October 16, 2026 at 05:10 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Susquehanna International Group, LLP | 0.87% |
| Virtu Financial LLC | 0.81% |
| HRT Financial LP | 0.71% |
| Fidelity | 0.7% |
| Morgan Stanley | 0.56% |
| Citadel | 0.42% |
| UBS Group AG | 0.25% |
| Jane Street Group, LLC | 0.21% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 1.35% |
| Geode Capital | 0.74% |
Source: Nexqual, October 16, 2026 at 05:10 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| KMTS | Kestra Medical Technologies, Lt | USD 28.68 | ▲ 6.34% |
| XRAY | DENTSPLY SIRONA Inc. | USD 8.83 | ▲ 3.76% |
| LMAT | LeMaitre Vascular, Inc. | USD 83.16 | ▲ 1.97% |
| ATRC | AtriCure, Inc. | USD 57.78 | ▲ 1.6% |
| WRBY | Warby Parker Inc. | USD 24.59 | ▼ 7.28% |
| PLSE | Pulse Biosciences, Inc | USD 45.59 | ▼ 6.08% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:10 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt